Adaptive radiation for prostate cancer in lymph nodes
Part of Cancer clinical trials.
This trial tests a type of targeted radiation (SBRT) for prostate cancer that has come back only in certain lymph nodes around the belly or hip. The goal is to see if adapting the radiation plan during treatment can make the response last longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of prostate cancer that started in the prostate gland (called adenocarcinoma).
- Your cancer must have come back in only a few spots, specifically in lymph nodes around your belly (para-aortic area) or near your hip (common iliac area).
- You can have up to 10 lymph nodes with cancer in those areas, as shown on a PSMA PET scan.
- You should be fairly active and able to take care of yourself (ECOG score of 0, 1, or 2).
- You must not have had radiation therapy to the para-aortic or common iliac area before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether targeted radiation to the lymph nodes in the belly can help men whose prostate cancer has returned in just a few spots after prior radiation. You must have had a PSMA PET/CT scan showing the cancer is limited to pelvic or belly lymph nodes.
This trial tests a precise type of radiation therapy (called SABR) for prostate cancer that has returned in the lymph nodes only. It aims to control the cancer with fewer side effects and might offer a treatment option when surgery or other standard treatments are no longer enough.
This trial tests a type of radiation that adjusts to changes in your prostate during treatment. It aims to improve accuracy and reduce side effects for men with intermediate- or high-risk prostate cancer.
This trial tests a new way to deliver targeted radiation for cancer that has spread to lymph nodes in the belly or pelvis. The radiation dose is adjusted during each session to better hit the tumor while protecting healthy tissue.
This trial tests a high-precision, short-course radiation treatment for prostate cancer that has spread to a few lymph nodes in the pelvis. The treatment uses weekly MRI or CT scans to adapt the radiation to your exact anatomy, aiming to target the cancer while protecting healthy tissue.
This trial tests a special type of radiation therapy for prostate cancer that adjusts to small changes in your body. It aims to better target the cancer while reducing side effects.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.